Clinical uses of cidofovir (Q33867391)

29 July 2017

title

Clinical uses of cidofovir (English)

1 reference

29 July 2017

Safrin S

1

1 reference

29 July 2017

Cherrington J

series ordinal

2

1 reference

29 July 2017

Jaffe HS

series ordinal

3

1 reference

29 July 2017

publication date

1 September 1997

1 reference

Reviews in Medical Virology

29 July 2017

published in

1 reference

29 July 2017

volume

7

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

145-156

1 reference

Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

Natural history of untreated cytomegalovirus retinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

A novel selective broad-spectrum anti-DNA virus agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

Synthesis and antiviral activity of the nucleotide analogue (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

Evaluation of Cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

Mechanism of uptake of the phosphonate analog (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in Vero cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

Activity of different antiviral drug combinations against human cytomegalovirus replication in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine in various models of herpes simplex virus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

Comparative activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against rat cytomegalovirus infection in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

(S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

A human cytomegalovirus mutant resistant to the nucleoside analog 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine (BW B759U) induces reduced levels of BW B759U triphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

Mutations in human cytomegalovirus UL97 gene confer clinical resistance to ganciclovir and can be detected directly in patient plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

A ganciclovir-resistant clinical isolate of human cytomegalovirus exhibiting cross-resistance to other DNA polymerase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

Isolation of Foscarnet-Resistant Human Cytomegalovirus Patterns of Resistance and Sensitivity to Other Antiviral Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

Prevalence of Resistance in Patients Receiving Ganciclovir for Serious Cytomegalovirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

Novel mutation in the UL97 gene of a clinical cytomegalovirus strain conferring resistance to ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

Biochemical basis for increased susceptibility to Cidofovir of herpes simplex viruses with altered or deficient thymidine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

Treatment of cytomegalovirus retinitis with intravitreous cidofovir in patients with AIDS. A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199709%297%3A3%3C145%3A%3AAID-RMV196%3E3.0.CO%3B2-0

10.1002/(SICI)1099-1654(199709)7:3<145::AID-RMV196>3.0.CO;2-0

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference